A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.


Updates from The Motley Fool

Latest updates on Alexion Pharmaceuticals from Fool.com.


Stock Performance

ALXN vs. S&P 500 | 2 Year Performance
View Interactive ALXN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alexion Pharmaceuticals.
Current Price: $129.78
Prev Close: $126.65
Open: $126.63
Bid: $124.15
Ask: $133.90
Day's Range: $125.81 - $130.32
52wk Range: $110.56 - $205.29
Volume: 2,110,740
Avg Vol 2,355,833
Market Cap: $29.24B
P/E (ttm): 201.03
EPS (ttm): $0.63
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alexion Pharmaceuticals.
CAPS Rating 3 out of 5
 
307 Outperform
56 Underperform
CAPS All Stars
 
71 Outperform
9 Underperform

How do you think Alexion Pharmaceuticals will perform against the market?



You pick for Alexion Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

David Hallal, CEO

62% Approve

Based on 20 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alexion Pharmaceuticals.

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers